## Consolidated Statement of Equity

**Year Ended**

|  | Jun 30, 2024 | Jun 30, 2023 |
| --- | --- | --- |
|       Total Stockholders' Equity - Beginning balance | 206,223 | 166,542 |
| *        Translation adjustments and other* | (2,962) | (2,734) |
| *        Retained earnings* | 173,144 | 118,848 |
| *        Accumulated other comprehensive income (loss)* | (5,590) | (6,343) |
| *        Derivatives* | (3) | (27) |
| *        Investments* | (2,625) | (3,582) |
| *        Common stock and paid-in capital* | 100,923 | 93,718 |
|       Common stock issued - Beginning balance |  |  |
| *        Common stock and paid-in capital - Ending balance* | 2,002 | 1,866 |
|       Net Income - Beginning balance | 88,136 | 72,361 |
| *        Retained earnings - Ending balance* | 88,136 | 72,361 |
|       Other comprehensive income (loss) - Beginning balance | 753 | (1,665) |
| *        Translation adjustments and other* | (228) | (207) |
| *        Investments* | 957 | (1,444) |
| *        Derivatives* | 24 | (14) |
| *        Accumulated other comprehensive income (loss) - Ending balance* | 753 | (1,665) |
|       Common stock cash dividends - Beginning balance | 22,296 | 20,230 |
| *        Retained earnings - Ending balance* | 22,293 | 20,226 |
|       Common stock repurchased - Beginning balance |  |  |
| *        Share Repurchase Program 2019 and 2021* |  |  |
| *        Retained earnings* | 11,547 | 17,568 |
| *        Common stock and paid-in capital* | 5,712 | 4,696 |
| *        Share Repurchase Program 2021* | 11,960 | 18,400 |
| *        Share Repurchase Program 2019 - Ending balance* |  |  |
|       Stock-based compensation expense - Beginning balance |  |  |
| *        Common stock and paid-in capital - Ending balance* | 10,734 | 9,611 |
|       Other, net - Beginning balance |  |  |
| *        Common stock and paid-in capital - Ending balance* | (181) | 2 |
|       Total Stockholders' Equity | 268,477 | 206,223 |
| *        Translation adjustments and other* | (2,962) | (2,734) |
| *        Retained earnings* | 173,144 | 118,848 |
| *        Accumulated other comprehensive income (loss)* | (5,590) | (6,343) |
| *        Derivatives* | (3) | (27) |
| *        Investments* | (2,625) | (3,582) |
| *        Common stock and paid-in capital - Ending balance* | 100,923 | 93,718 |
|       Cash dividends declared per common share | 3.00 | 2.72 |